Treatment Outcomes and Prognostic Factors of Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and Fluorouracil in Advanced Head and Neck Cancer

Takahiro Kusaka(Iwate Medical University), Kozo Tanno(Iwate Medical University), Yu Ohashi, Kodai Tsuchida(Iwate Medical University), Jun Miyaguchi(Iwate Medical University), Daisuke Saito(Iwate Medical University), K. Katagiri(Iwate Medical University), Hisanori Ariga(Iwate Medical University), Shinichi Oikawa(Fukujuji Hospital), Aya Ikeda(Juntendo University), Kiyoto Shiga(Iwate Medical University)
Anticancer Research
December 1, 2022
10.21873/anticanres.16116
Cited by 3

Related Papers

Genome-wide association study identifies 112 new loci for body mass index in the Japanese population
|Nature Genetics|2017|510
The Tohoku Medical Megabank Project: Design and Mission
|Journal of Epidemiology|2016|386
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or Older With Atherosclerotic Risk Factors
|JAMA|2014|304
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
|Nature Genetics|2019|273
Characterizing rare and low-frequency height-associated variants in the Japanese population
|Nature Communications|2019|201